Search research articles
Contact Us
Filters
Showing results (321-330 of 436) with videos related to
Page
of 44
Sort By:
Lancet (London, England)
|
March 17, 2009
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study
Richard C Becker, David J Moliterno, Lisa K Jennings, et al.
Circulation. Cardiovascular Genetics
|
March 10, 2015
NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes: Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO)
Åsa Johansson, Niclas Eriksson, Richard C Becker, et al.
American Heart Journal
|
July 12, 2011
Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration
L Kristin Newby, Ignacio Rodriguez, John Finkle, et al.
Journal of Thrombosis and Thrombolysis
|
June 14, 2017
Platelet-related biomarkers and their response to inhibition with aspirin and p2y<sub>12</sub>-receptor antagonists in patients with acute coronary syndrome
Angela Lowenstern, Robert F Storey, Megan Neely, et al.
Clinical Chemistry
|
December 10, 2016
Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome
Daniel Lindholm, Stefan K James, Maria Bertilsson, et al.
Journal of Thrombosis and Thrombolysis
|
June 25, 2005
Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee
E Magnus Ohman, Christopher B Granger, Lawrence Rice, et al.
Hypertension (Dallas, Tex. : 1979)
|
October 26, 2018
Prediction of Ambulatory Hypertension Based on Clinic Blood Pressure Percentile in Adolescents
Gilad Hamdani, Joseph T Flynn, Richard C Becker, et al.
American Heart Journal
|
February 15, 2011
A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial
Thomas J Povsic, Mauricio G Cohen, Roxana Mehran, et al.
Journal of the American College of Cardiology
|
October 2, 2012
Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery
Christoph Varenhorst, Ulrica Alström, Benjamin M Scirica, et al.
Circulation
|
July 1, 2016
On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF
Christopher B Fordyce, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Page
of 44
Search research articles
Search
Showing results (321-330 of 436) with videos related to
Sort By:
Page
of 44
Lancet (London, England)
|
March 17, 2009
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study
Richard C Becker, David J Moliterno, Lisa K Jennings, et al.
Circulation. Cardiovascular Genetics
|
March 10, 2015
NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes: Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO)
Åsa Johansson, Niclas Eriksson, Richard C Becker, et al.
American Heart Journal
|
July 12, 2011
Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration
L Kristin Newby, Ignacio Rodriguez, John Finkle, et al.
Journal of Thrombosis and Thrombolysis
|
June 14, 2017
Platelet-related biomarkers and their response to inhibition with aspirin and p2y<sub>12</sub>-receptor antagonists in patients with acute coronary syndrome
Angela Lowenstern, Robert F Storey, Megan Neely, et al.
Clinical Chemistry
|
December 10, 2016
Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome
Daniel Lindholm, Stefan K James, Maria Bertilsson, et al.
Journal of Thrombosis and Thrombolysis
|
June 25, 2005
Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee
E Magnus Ohman, Christopher B Granger, Lawrence Rice, et al.
Hypertension (Dallas, Tex. : 1979)
|
October 26, 2018
Prediction of Ambulatory Hypertension Based on Clinic Blood Pressure Percentile in Adolescents
Gilad Hamdani, Joseph T Flynn, Richard C Becker, et al.
American Heart Journal
|
February 15, 2011
A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial
Thomas J Povsic, Mauricio G Cohen, Roxana Mehran, et al.
Journal of the American College of Cardiology
|
October 2, 2012
Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery
Christoph Varenhorst, Ulrica Alström, Benjamin M Scirica, et al.
Circulation
|
July 1, 2016
On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF
Christopher B Fordyce, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Page
of 44